Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease
about
Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.Effect of inhaled corticosteroids on lung function in chronic beryllium disease.
P2860
Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Infliximab therapy modulates a ...... e in chronic beryllium disease
@ast
Infliximab therapy modulates a ...... e in chronic beryllium disease
@en
type
label
Infliximab therapy modulates a ...... e in chronic beryllium disease
@ast
Infliximab therapy modulates a ...... e in chronic beryllium disease
@en
prefLabel
Infliximab therapy modulates a ...... e in chronic beryllium disease
@ast
Infliximab therapy modulates a ...... e in chronic beryllium disease
@en
P2093
P2860
P1433
P1476
Infliximab therapy modulates a ...... e in chronic beryllium disease
@en
P2093
Allison Martin
Andrew P Fontenot
Briana Q Barkes
Douglas G Mack
Juliana Barnard
Lee S Newman
Lisa A Maier
Lori Silveira
Margaret Mroz
May Gillespie
P2860
P304
P356
10.1016/J.RMED.2012.08.014
P577
2012-09-11T00:00:00Z